Stericycle, Inc. (NASDAQ:SRCL – Free Report) – Investment analysts at Zacks Research cut their Q3 2023 earnings estimates for shares of Stericycle in a report issued on Thursday, August 10th. Zacks Research analyst S. Bose now expects that the business services provider will post earnings per share of $0.38 for the quarter, down from their prior forecast of $0.46. The consensus estimate for Stericycle’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for Stericycle’s Q4 2023 earnings at $0.45 EPS, FY2023 earnings at $1.75 EPS, Q1 2024 earnings at $0.53 EPS and Q3 2024 earnings at $0.56 EPS.
Stericycle (NASDAQ:SRCL – Get Free Report) last released its quarterly earnings results on Thursday, July 27th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.06). The company had revenue of $669.50 million for the quarter, compared to analysts’ expectations of $683.48 million. Stericycle had a return on equity of 8.31% and a net margin of 0.79%. The business’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.48 EPS.
Read Our Latest Analysis on Stericycle
Stericycle Stock Performance
Shares of SRCL stock opened at $45.38 on Monday. Stericycle has a 52 week low of $39.63 and a 52 week high of $56.12. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.52. The company has a market cap of $4.20 billion, a PE ratio of 197.31, a P/E/G ratio of 3.06 and a beta of 1.22. The company’s fifty day simple moving average is $44.98 and its 200-day simple moving average is $45.62.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. Exchange Traded Concepts LLC bought a new stake in shares of Stericycle in the 2nd quarter valued at $25,000. BOKF NA purchased a new position in shares of Stericycle in the 1st quarter worth approximately $29,000. Quarry LP bought a new stake in shares of Stericycle during the 1st quarter worth $30,000. Ancora Advisors LLC bought a new stake in Stericycle in the first quarter worth about $34,000. Finally, International Assets Investment Management LLC purchased a new position in Stericycle in the first quarter valued at about $35,000. Institutional investors own 97.14% of the company’s stock.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, controlled substance waste disposal, healthcare hazardous waste, and COVID 19 waste disposal; specialty services, such as MedDrop medication collection kiosks, safe community solutions, sharps mailback solutions, and maritime waste services; medical supply store services; pharmaceutical waste services; hazardous waste disposal; compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.
See Also
- Five stocks we like better than Stericycle
- How to Invest in Hotel Stocks
- MarketBeat Week in Review – 8/7 – 8/11
- Energy and Oil Stocks Explained
- 3 Retailers To Watch Closely Next Week
- What is the Euro STOXX 50 Index?
- Investing in Coffee: 3 Great Strategies to Consider
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.
